CAS 1334244-28-8
:Sitagliptin Impurity 31
Description:
Sitagliptin Impurity 31, with the CAS number 1334244-28-8, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent sitagliptin, which is used primarily in the treatment of type 2 diabetes. As an impurity, it may arise during the synthesis or degradation of sitagliptin and is typically characterized by its molecular structure, which includes specific functional groups that can influence its chemical behavior and stability. The compound's characteristics, such as solubility, melting point, and reactivity, are important for quality control in pharmaceutical formulations. Impurities like Sitagliptin Impurity 31 are monitored to ensure the safety and efficacy of the final drug product. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities in pharmaceutical preparations. Understanding the properties of impurities is crucial for regulatory compliance and ensuring that medications meet the required standards for patient safety.
Formula:C16H16F5N5O
Synonyms:- 1-Butanone, 3-amino-4-(2,4-difluorophenyl)-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-
- Sitagliptin Impurity 31
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
